GI Innovation, Inc. (KOSDAQ:358570)
18,890
+70 (0.37%)
At close: Dec 5, 2025
GI Innovation Revenue
GI Innovation had revenue of 338.09M KRW in the twelve months ending September 30, 2025, down -92.89% year-over-year. In the year 2024, GI Innovation had annual revenue of 24.28M, down -99.54%.
Revenue (ttm)
338.09M
Revenue Growth
-92.89%
P/S Ratio
3,557.66
Revenue / Employee
n/a
Employees
n/a
Market Cap
1,202.80B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 5,504.84B |
| Celltrion | 3,895.99B |
| ALTEOGEN | 202.18B |
| ABL Bio | 88.44B |
| SK Biopharmaceuticals | 675.41B |
| Yuhan | 2,136.67B |
| LigaChem Biosciences | 159.27B |
| Peptron | 6.19B |